Sign in
8-K/A

Current Report

SELLAS Life Sciences Group, Inc. Filed Acc 0001193125-18-008997

Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Other events

  • Item 2.01 Completion of acquisition or disposition of assets
  • Item 3.03 Material modification to rights of security holders
  • Item 5.01 Changes in control of the registrant
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.05 Amendment to or waiver of the code of ethics
  • Item 5.07 Submission of matters to a vote of security holders
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading d525391d8ka.htm…